PE-backed Nexelis to buy ImmunXperts

Nexelis, a portfolio company of Ampersand Capital Partners, has agreed to acquire ImmunXperts, a Belgian provider of in-vitro immunology services.

4 March 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles